Advances in emerging therapies 2006

被引：7

作者：

Lees, Kennedy R.

Dawson, Jesse ^{[1
]}

机构：

[1] Univ Glasgow, Western Infirm, Acute Stroke Unit, Glasgow G11 6NT, Lanark, Scotland

[2] Univ Glasgow, Western Infirm, Cerebrovasc Clin, Div Cardiovasc & Med Sci, Glasgow G11 6NT, Lanark, Scotland

来源：

STROKE | 2007年 / 38卷 / 02期

关键词：

antiplatelet; CT perfusion; magnetic resonance imaging; neuroprotection; reperfusion; secondary prevention; thrombolysis;

D O I：

10.1161/01.STR.0000254718.22566.90

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：219 / 221

页数：3

共 20 条

[1]

Amarenco P, 2006, NEW ENGL J MED, V355, P549

[2] Reduction of diffusion-weighted MRI lesion volume after early moderate hypothermia in ischemic stroke [J].

Berger, C ;

Schramm, P ;

Schwab, S .

STROKE, 2005, 36 (06) :E56-E58

[3] Mechanical thrombolysis in ischemic stroke attributable to basilar artery occlusion as first-line treatment [J].

Bergui, M ;

Stura, G ;

Daniele, D ;

Cerrato, P ;

Berardino, M ;

Bradac, GB .

STROKE, 2006, 37 (01) :145-150

[4] Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events [J].

Bhatt, DL ;

Fox, KAA ;

Hacke, W ;

Berger, PB ;

Black, HR ;

Boden, WE ;

Cacoub, P ;

Cohen, EA ;

Creager, MA ;

Easton, JD ;

Flather, MD ;

Haffner, SM ;

Hamm, CW ;

Hankey, GJ ;

Johnston, SC ;

Mak, KH ;

Mas, JL ;

Montalescot, G ;

Pearson, TA ;

Steg, PG ;

Steinhubl, SR ;

Weber, MA ;

Brennan, DM ;

Fabry-Ribaudo, L ;

Booth, J ;

Topol, EJ ;

Frye, RL ;

Amarenco, P ;

Brass, LM ;

Buyse, M ;

Cohen, LS ;

DeMets, DL ;

Fuster, V ;

Hart, RG ;

Marler, JR ;

McCarthy, C ;

Schoemig, A ;

Lincoff, AM ;

Brener, SJ ;

Sila, CA ;

Albuquerque, A ;

Aroutiounov, G ;

Artemiev, D ;

Atkeson, BG ;

Bartel, T ;

Basart, DCG ;

Lima, AB ;

Belli, G ;

Bordalo e Sa, AL ;

Bosch, X .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) :1706-1717

[5] European stroke prevention study .2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke [J].

Diener, HC ;

Cunha, L ;

Forbes, C ;

Sivenius, J ;

Smets, P ;

Lowenthal, A .

JOURNAL OF THE NEUROLOGICAL SCIENCES, 1996, 143 (1-2) :1-13

[6] Dose escalation of desmoteplase for acute ischemic stroke (DEDAS) - Evidence of safety and efficacy 3 to 9 hours after stroke onset [J].

Furlan, AJ ;

Eyding, D ;

Albers, GW ;

Al-Rawi, Y ;

Lees, KR ;

Rowley, HA ;

Sachara, C ;

Soehngen, M ;

Warach, S ;

Hacke, W .

STROKE, 2006, 37 (05) :1227-1231

[7] Hemicraniectomy for massive middle cerebral artery territory infarction - A systematic review [J].

Gupta, R ;

Connolly, ES ;

Mayer, S ;

Elkind, MSV .

STROKE, 2004, 35 (02) :539-543

[8] The Desmoteplase In Acute Ischemic Stroke Trial (DIAS) - A phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase [J].

Hacke, W ;

Albers, G ;

Al-Rawi, Y ;

Bogousslavsky, J ;

Davalos, A ;

Eliasziw, M ;

Fischer, M ;

Furlan, A ;

Kaste, M ;

Lees, KR ;

Soehngen, M ;

Warach, S .

STROKE, 2005, 36 (01) :66-73

[9]

Halkes PHA, 2006, LANCET, V367, P1665

[10] Intracranial angioplasty and stenting for cerebral atherosclerosis: new treatments for stroke are needed! [J].

Higashida, Randall T. ;

Meyers, Philip M. .

NEURORADIOLOGY, 2006, 48 (06) :367-372

← 1 2 →